Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Clinical Research of Human Mesenchymal Stem Cells in the Treatment of COVID-19 Pneumonia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04339660
Recruitment Status : Recruiting
First Posted : April 9, 2020
Last Update Posted : April 9, 2020
Sponsor:
Collaborators:
Shanghai University
Qingdao Co-orient Watson Biotechnology group co. LTD
Chinese Academy of Medical Sciences
Information provided by (Responsible Party):
Puren Hospital Affiliated to Wuhan University of Science and Technology

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : June 30, 2020
Estimated Study Completion Date : June 30, 2020